{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T18:07:03Z","timestamp":1773425223733,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12264-025-01509-x","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T07:35:07Z","timestamp":1758353707000},"page":"605-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Potential Transmission of Alpha-Synuclein from the Gastrointestinal Tract to the Substantia Nigra along the Vagal Afferent Pathway"],"prefix":"10.1007","volume":"42","author":[{"given":"Fan","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4257-7820","authenticated-orcid":false,"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1524-7519","authenticated-orcid":false,"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"1509_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: Risk factors and prevention. Lancet Neurol 2016, 15: 1257\u20131272.","journal-title":"Lancet Neurol"},{"key":"1509_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12264-022-00957-z","volume":"39","author":"R Wang","year":"2023","unstructured":"Wang R, Ren H, Kaznacheyeva E, Lu X, Wang G. Association of glial activation and \u03b1-synuclein pathology in Parkinson\u2019s disease. Neurosci Bull 2023, 39: 479\u2013490.","journal-title":"Neurosci Bull"},{"key":"1509_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/538S1a","volume":"538","author":"M Grayson","year":"2016","unstructured":"Grayson M. Parkinson\u2019s disease. Nature 2016, 538: S1.","journal-title":"Nature"},{"key":"1509_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, R\u00fcb U, De Vos RAI, Bohl JRE, Braak H. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002, 61: 413\u2013426.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1509_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJA, Kraneveld AD. Exploring braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol 2017, 8: 37.","journal-title":"Front Neurol"},{"key":"1509_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","volume":"39","author":"HN Costa","year":"2023","unstructured":"Costa HN, Esteves AR, Empadinhas N, Cardoso SM. Parkinson\u2019s disease: A multisystem disorder. Neurosci Bull 2023, 39: 113\u2013124.","journal-title":"Neurosci Bull"},{"key":"1509_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","volume":"14","author":"S George","year":"2019","unstructured":"George S, Rey NL, Tyson T, Esquibel C, Meyerdirk L, Schulz E. Microglia affect \u03b1-synuclein cell-to-cell transfer in a mouse model of Parkinson\u2019s disease. Mol Neurodegener 2019, 14: 34.","journal-title":"Mol Neurodegener"},{"key":"1509_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12264-023-01115-9","volume":"40","author":"C Hu","year":"2024","unstructured":"Hu C, Yan Y, Jin Y, Yang J, Xi Y, Zhong Z. Decoding the cellular trafficking of prion-like proteins in neurodegenerative diseases. Neurosci Bull 2024, 40: 241\u2013254.","journal-title":"Neurosci Bull"},{"key":"1509_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease\u2014the gut-brain axis and environmental factors. Nat Rev Neurol 2015, 11: 625\u2013636.","journal-title":"Nat Rev Neurol"},{"key":"1509_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 2019, 103: 627-641.e7.","journal-title":"Neuron"},{"key":"1509_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2018.10.018","volume":"175","author":"W Han","year":"2018","unstructured":"Han W, Tellez LA, Perkins MH, Perez IO, Qu T, Ferreira J, et al. A neural circuit for gut-induced reward. Cell 2018, 175: 887\u2013888.","journal-title":"Cell"},{"key":"1509_CR12","doi-asserted-by":"publisher","first-page":"eaat5236","DOI":"10.1126\/science.aat5236","volume":"361","author":"MM Kaelberer","year":"2018","unstructured":"Kaelberer MM, Buchanan KL, Klein ME, Barth BB, Montoya MM, Shen X, et al. A gut-brain neural circuit for nutrient sensory transduction. Science 2018, 361: eaat5236.","journal-title":"Science"},{"key":"1509_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172192","volume":"8","author":"R Chandra","year":"2023","unstructured":"Chandra R, Sokratian A, Chavez KR, King S, Swain SM, Snyder JC, et al. Gut mucosal cells transfer \u03b1-synuclein to the vagus nerve. JCI Insight 2023, 8: e172192.","journal-title":"JCI Insight"},{"key":"1509_CR14","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"B Liu","year":"2017","unstructured":"Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, et al. Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study. Neurology 2017, 88: 1996\u20132002.","journal-title":"Neurology"},{"key":"1509_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol 2015, 78: 522\u2013529.","journal-title":"Ann Neurol"},{"key":"1509_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s40473-014-0010-5","volume":"1","author":"RH Howland","year":"2014","unstructured":"Howland RH. Vagus nerve stimulation. Curr Behav Neurosci Rep 2014, 1: 64\u201373.","journal-title":"Curr Behav Neurosci Rep"},{"key":"1509_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(17)30037-6","volume":"16","author":"BE Stopschinski","year":"2017","unstructured":"Stopschinski BE, Diamond MI. The prion model for progression and diversity of neurodegenerative diseases. Lancet Neurol 2017, 16: 323\u2013332.","journal-title":"Lancet Neurol"},{"key":"1509_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104623","volume":"134","author":"C Mezias","year":"2020","unstructured":"Mezias C, Rey N, Brundin P, Raj A. Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation. Neurobiol Dis 2020, 134: 104623.","journal-title":"Neurobiol Dis"},{"key":"1509_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbrc.2021.03.029","volume":"552","author":"X Wang","year":"2021","unstructured":"Wang X, Shinkai Y, Doi M. Retrogradely transmitted \u03b1-synuclein is taken up by the endophilin-independent endocytosis in the C. elegans neural circuit. Biochem Biophys Res Commun 2021, 552: 176\u2013182.","journal-title":"Biochem Biophys Res Commun"},{"key":"1509_CR20","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1007\/s11064-023-03983-z","volume":"48","author":"OME Abdel-Salam","year":"2023","unstructured":"Abdel-Salam OME, M\u00f3zsik G. Capsaicin, the vanilloid receptor TRPV1 agonist in neuroprotection: Mechanisms involved and significance. Neurochem Res 2023, 48: 3296\u20133315.","journal-title":"Neurochem Res"},{"key":"1509_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-1-0716-2364-0_21","volume":"2506","author":"JC Wang","year":"2022","unstructured":"Wang JC, Crosson T, Talbot S. Analysis of airway vagal neurons. Methods Mol Biol 2022, 2506: 297\u2013314.","journal-title":"Methods Mol Biol"},{"key":"1509_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cne.902710109","volume":"271","author":"S Ritter","year":"1988","unstructured":"Ritter S, Dinh TT. Capsaicin-induced neuronal degeneration: Silver impregnation of cell bodies, axons, and terminals in the central nervous system of the adult rat. J Comp Neurol 1988, 271: 79\u201390.","journal-title":"J Comp Neurol"},{"key":"1509_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejphar.2005.05.002","volume":"517","author":"B Jakab","year":"2005","unstructured":"Jakab B, Helyes Z, Varga A, B\u00f6lcskei K, Szab\u00f3 A, S\u00e1ndor K, et al. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat. Eur J Pharmacol 2005, 517: 35\u201344.","journal-title":"Eur J Pharmacol"},{"key":"1509_CR24","doi-asserted-by":"publisher","first-page":"103908","DOI":"10.1016\/j.isci.2022.103908","volume":"25","author":"DP Amorim Neto","year":"2022","unstructured":"Amorim Neto DP, Bosque BP, Pereira de Godoy JV, Rodrigues PV, Meneses DD, Tostes K, et al. Akkermansia muciniphila induces mitochondrial calcium overload and \u03b1-synuclein aggregation in an enteroendocrine cell line. iScience 2022, 25: 103908.","journal-title":"iScience"},{"key":"1509_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2022.02.006","volume":"529","author":"R Chen","year":"2022","unstructured":"Chen R, Gu X, Wang X. \u03b1-Synuclein in Parkinson\u2019s disease and advances in detection. Clin Chim Acta 2022, 529: 76\u201386.","journal-title":"Clin Chim Acta"},{"key":"1509_CR26","first-page":"AF01","volume":"11","author":"SP Maniyath","year":"2017","unstructured":"Maniyath SP, Solaiappan N, Rathinasamy M. Neurobehavioural changes in a hemiparkinsonian rat model induced by rotenone. J Clin Diagn Res 2017, 11: AF01\u2013AF05.","journal-title":"J Clin Diagn Res"},{"key":"1509_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, et al. Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 2010, 5: e8762.","journal-title":"PLoS One"},{"key":"1509_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119417","volume":"1870","author":"T Roy","year":"2023","unstructured":"Roy T, Chatterjee A, Swarnakar S. Rotenone induced neurodegeneration is mediated via cytoskeleton degradation and necroptosis. Biochim Biophys Acta Mol Cell Res 2023, 1870: 119417.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1509_CR29","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2016.10.046","volume":"152","author":"KN Browning","year":"2017","unstructured":"Browning KN, Verheijden S, Boeckxstaens GE. The vagus nerve in appetite regulation, mood, and intestinal inflammation. Gastroenterology 2017, 152: 730\u2013744.","journal-title":"Gastroenterology"},{"key":"1509_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2051-5960-1-2","volume":"1","author":"NP Visanji","year":"2013","unstructured":"Visanji NP, Brooks PL, Hazrati LN, Lang AE. The prion hypothesis in Parkinson\u2019s disease: Braak to the future. Acta Neuropathol Commun 2013, 1: 2.","journal-title":"Acta Neuropathol Commun"},{"key":"1509_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-019-0331-7","volume":"14","author":"N Uemura","year":"2019","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Correction to: Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener 2019, 14: 31.","journal-title":"Mol Neurodegener"},{"key":"1509_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","volume":"112","author":"FP Manfredsson","year":"2018","unstructured":"Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, et al. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis 2018, 112: 106\u2013118.","journal-title":"Neurobiol Dis"},{"key":"1509_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"D James Surmeier","year":"2017","unstructured":"James Surmeier D, Obeso JA, Halliday GM. Selective neuronal vulnerability in parkinson disease. Nat Rev Neurosci 2017, 18: 101\u2013113.","journal-title":"Nat Rev Neurosci"},{"key":"1509_CR34","doi-asserted-by":"publisher","first-page":"BSR20191796","DOI":"10.1042\/BSR20191796","volume":"40","author":"J Liu","year":"2020","unstructured":"Liu J, Liu H, Zhao Z, Wang J, Guo D, Liu Y. Regulation of Actg1 and Gsta2 is possible mechanism by which capsaicin alleviates apoptosis in cell model of 6-OHDA-induced Parkinson\u2019s disease. Biosci Rep 2020, 40: BSR20191796.","journal-title":"Biosci Rep"},{"key":"1509_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.159","volume":"49","author":"YC Chung","year":"2017","unstructured":"Chung YC, Baek JY, Kim SR, Ko HW, Bok E, Shin WH, et al. Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson\u2019s disease. Exp Mol Med 2017, 49: e298.","journal-title":"Exp Mol Med"},{"key":"1509_CR36","doi-asserted-by":"publisher","first-page":"C112","DOI":"10.1152\/ajpcell.00409.2023","volume":"326","author":"RA Arnold","year":"2024","unstructured":"Arnold RA, Fowler DK, Peters JH. TRPV1 enhances cholecystokinin signaling in primary vagal afferent neurons and mediates the central effects on spontaneous glutamate release in the NTS. Am J Physiol Cell Physiol 2024, 326: C112\u2013C124.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1509_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40265-020-01429-2","volume":"81","author":"M Iftinca","year":"2021","unstructured":"Iftinca M, Defaye M, Altier C. TRPV1-targeted drugs in development for human pain conditions. Drugs 2021, 81: 7\u201327.","journal-title":"Drugs"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01509-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:01:12Z","timestamp":1772269272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01509-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1509"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01509-x","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,20]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}